Open access
Sep 2026
Temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggest a window of opportunity for checkpoint inhibitor therapy in prostate cancer
The induction of a bi-phasic response in the TiME is revealed: robust CTL activation 3–5 months after nADT is initiated, followed by myeloid immunosuppression in tumors receiving prolonged nADT.
Anmbreen Jamroze, Ren-Yuan Zhang, Emily M. Dougherty et al.
· Journal for ImmunoTherapy of... · 0 citations